-
1
-
-
0037274842
-
Heparin derivatives as angiogenesis inhibitors
-
Presta M, Leali D, Stabile H, Ronca R, Camozzi M, Coco L, Moroni E, Liekens S, Rusnati M. Heparin derivatives as angiogenesis inhibitors. Curr Pharmac Design. 2003;9:553-566.
-
(2003)
Curr Pharmac Design
, vol.9
, pp. 553-566
-
-
Presta, M.1
Leali, D.2
Stabile, H.3
Ronca, R.4
Camozzi, M.5
Coco, L.6
Moroni, E.7
Liekens, S.8
Rusnati, M.9
-
2
-
-
0242469234
-
Heparin inhibition of endothelial cell proliferation and organization in dependent on molecular weight
-
Khorana AA, Sahni A, Altland OD, Francis CW. Heparin inhibition of endothelial cell proliferation and organization in dependent on molecular weight. Arterioscler Thromb Vasc Biol. 2003;23:2110-2115.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 2110-2115
-
-
Khorana, A.A.1
Sahni, A.2
Altland, O.D.3
Francis, C.W.4
-
3
-
-
0038206935
-
An expanding role for antithrombotic therapy in cancer patients
-
Kakkar AK. An expanding role for antithrombotic therapy in cancer patients. Cancer Treat Rev. 2003;29:23-26.
-
(2003)
Cancer Treat Rev
, vol.29
, pp. 23-26
-
-
Kakkar, A.K.1
-
4
-
-
0020572581
-
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone
-
Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science. 1983;221:719-725.
-
(1983)
Science
, vol.221
, pp. 719-725
-
-
Folkman, J.1
Langer, R.2
Linhardt, R.J.3
Haudenschild, C.4
Taylor, S.5
-
5
-
-
0021359304
-
Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor
-
Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science. 1984;223:1296-1299.
-
(1984)
Science
, vol.223
, pp. 1296-1299
-
-
Shing, Y.1
Folkman, J.2
Sullivan, R.3
Butterfield, C.4
Murray, J.5
Klagsbrun, M.6
-
6
-
-
0035210065
-
Syndecan-4-mediated signaling
-
Simons M, Horowitz A. Syndecan-4-mediated signaling. Cell Signal. 2001;13:855-862.
-
(2001)
Cell Signal
, vol.13
, pp. 855-862
-
-
Simons, M.1
Horowitz, A.2
-
7
-
-
0037418264
-
Structural specificity of heparin binding in the fibroblast growth factor family of proteins
-
Raman R, Venkataraman G, Ernst S, Sasisekharan V, Sasisekharan R. Structural specificity of heparin binding in the fibroblast growth factor family of proteins. Proc Natl Acad Sci U S A. 2003;100:2357-2362.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 2357-2362
-
-
Raman, R.1
Venkataraman, G.2
Ernst, S.3
Sasisekharan, V.4
Sasisekharan, R.5
-
8
-
-
0037086082
-
VEGF isoform expression as a determinant of blood vessel patterning in human melanoma xenografts
-
Yu J, Rak JW, Klement G, Kerbel RS. VEGF isoform expression as a determinant of blood vessel patterning in human melanoma xenografts. Cancer Res. 2002:62:1838-1846.
-
(2002)
Cancer Res
, vol.62
, pp. 1838-1846
-
-
Yu, J.1
Rak, J.W.2
Klement, G.3
Kerbel, R.S.4
-
9
-
-
0034600424
-
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndromes without ST elevation: A meta-analysis
-
Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndromes without ST elevation: a meta-analysis. Lancet. 2000;335:1936-1942.
-
(2000)
Lancet
, vol.335
, pp. 1936-1942
-
-
Eikelboom, J.W.1
Anand, S.S.2
Malmberg, K.3
Weitz, J.I.4
Ginsberg, J.S.5
Yusuf, S.6
-
10
-
-
0033612915
-
Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomized multicentre study
-
FRagmin and Fast Revascularisation during InStability Coronary artery disease Investigators
-
FRISC II Investigators. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. FRagmin and Fast Revascularisation during InStability Coronary artery disease Investigators. Lancet 1999;354:701-707.
-
(1999)
Lancet
, vol.354
, pp. 701-707
-
-
-
11
-
-
0032870952
-
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial
-
Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999;100:1593-1601.
-
(1999)
Circulation
, vol.100
, pp. 1593-1601
-
-
Antman, E.M.1
McCabe, C.H.2
Gurfinkel, E.P.3
Turpie, A.G.4
Bernink, P.J.5
Salein, D.6
Bayes De Luna, A.7
Fox, K.8
Lablanche, J.M.9
Radley, D.10
Premmereur, J.11
Braunwald, E.12
-
12
-
-
0028356326
-
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
-
Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994;90:61-68.
-
(1994)
Circulation
, vol.90
, pp. 61-68
-
-
Merlini, P.A.1
Bauer, K.A.2
Oltrona, L.3
Ardissino, D.4
Cattaneo, M.5
Belli, C.6
Mannucci, P.M.7
Rosenberg, R.D.8
|